FILE:MDT/MDT-8K-20040820163618.txt.gz
EVENTS:	Other events
TEXT:
ITEM: Other events
 
 
Item 5.                    Other Events and Regulation FD Disclosure
 
Medtronic has increased the maximum amount of commercial paper authorized for issuance under its commercial paper program from $1.5 billion to $2.25 billion and has been notified by Standard & Poor's Ratings Services and Moody's Investors Service that they have reaffirmed Medtronic's short-term debt ratings of A-1+ and P-1, respectively, for the increased program.  Medtronic's commercial paper program, which has been in existence since 2001, allows Medtronic to issue debt securities with maturities of up to 364 days.  At July 30, 2004, outstanding commercial paper under Medtronic's program totaled approximately $250 million.  Commercial paper under Medtronic's program is offered and sold privately though selected dealers engaged by Medtronic.  The paper is offered and sold without registration under federal securities laws pursuant to exemption from such registration requirements.
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly  authorized.
 
 


